Empowering Immigrants in the Greater Boston Area to Connect to HBV Care
NCT ID: NCT02342821
Last Updated: 2017-03-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
100 participants
OBSERVATIONAL
2015-02-28
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optimizing HBV Care Cascade Among Foreign-Born in the United States (FOCUS-HBV Study)
NCT05621304
Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response
NCT04326803
Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India
NCT01772121
Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico
NCT02112890
Intrafamilial Transmission of Hepatitis B Virus: Frequency, Risk Factors, and Role of Hepatitis B Vaccination
NCT05523921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Provide HBV education at community sites where immigrants at risk for HBV could be informed of the risks related to HBV, in a culturally and linguistically sensitive manner.
1. Chelsea, Charlestown, and Revere MGH Community Health Centers: posters, pamphlets, and telephone line to provide HBV education
2. Senegalese Community Center: community meeting, posters, and pamphlets
3. African Students' Association, Suffolk University: community meeting, posters, and pamphlets
4. Revere Cambodian Community Centers: community meeting, posters, and pamphlets
2. Provide at-risk persons with the tools to develop an HBV diagnosis plan with his / her provider.
1. Provide counseling on the significance of different testing results prior to testing
2. Connect to testing, and appropriate post-test follow-up appointments
3. Provide an education hub for patients and providers to return to with questions regarding: test interpretation, available treatments for those who test positive, and screening for hepatocellular carcinoma in those who are infected.
1. Provide copy of an easy to understand US HBV treatment algorithm in native languages
2. Provide information related to genotype-specific risks for HCC (increased with GT C).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gilead Sciences
INDUSTRY
Massachusetts General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fusco, Dahlene N.,M.D.,Ph.D.
Physician
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IN-US-174-1254
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.